does semaglutide reduce visceral fat Semaglutide-Mediated Remodeling of Adipose Tissue in Type 2 Diabetes: Molecular Mechanisms Beyond Glycemic Control The Hidden Danger: Visceral Fat

January 2nd, 2025: Ozempic lawsuit reaches 1,331 cases as gastroparesis claims continue to mount The Ozempic Lawsuit centers on claims that the diabetes and weight loss medication Ozempic has led to severe gastrointestinal side effects, including gastroparesis, nausea, and vomiting

The new oral Wegovy weight loss pill has launched at Boots Online Doctor with eligible customers able to collect medication in-store or receive home delivery from today, once approved

The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer

The FDA has sent warning letters to multiple telehealth companies and has drawn a clear distinction between mass-marketed compounded products and patient-specific compounding that may remain permissible in narrow circumstances

Benefits beyond weight loss and blood sugar GLP-1 medications are not only about the scale

Sasaki S, Sun R, Bui HH, Crosby JR, Monia BP, Guo S